Can a new serum fix 'Ozempic Face'? trial seeks answers
NCT ID NCT07216352
Summary
This study is testing a topical serum to see if it safely improves the appearance of aging skin, like fine lines and sagging. It will enroll 25 adults who are currently using GLP-1 weight loss drugs like Ozempic or Wegovy. Participants will apply the serum to their face and neck twice daily for 12 weeks, and researchers will measure changes in skin quality.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAXITY; SKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West Dermatology Research Center
San Diego, California, 92121, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.